KXII Health Headlines

Unapproved device buys time for new pair of lungs

Posted: 07/02/2014 - PITTSBURGH (AP) - An Oklahoma man is slowly gaining strength at a Pittsburgh hospital with a second set of transplanted lungs in a procedure that was possible only through a device that until now hasn't been used in the U.S.

Warning signs and how to prevent a drowning

Updated: 06/19/2014 - DENISON, TX -- As the temperatures rise in Texoma, lifeguards and emergency crews are concerned about an increase in drowning accidents as more people hit the water.

FDA prepping long-awaited plan to reduce salt

Posted: 06/17/2014 - WASHINGTON (AP) - Food companies and restaurants could soon face government pressure to make their foods less salty - a long-awaited federal effort to try to prevent thousands of deaths each year from heart disease and stroke.

Safe Family: BB gun problems

Posted: 05/22/2014 - IOWA -- An Iowa woman is warning parents about the dangers of BB guns. She was hit in the chest and it is now lodged in her body. Vanessa Peng has her story in today's safe family report.
Video

Kids get codeine in ER despite risks, guidelines

Posted: 04/21/2014 - CHICAGO (AP) - Despite recommended limits on codeine use in children, the potent painkiller is prescribed for children in at least half a million emergency room visits each year, a study suggests.

More KXII Health Headlines

CBS News Health Headlines

WebMD Health News

AP Top Health Stories

  • Cricket-Fractured cheekbone lucky escape from bouncer - Shehzad
    KARACHI, Nov 27 (Reuters) - Pakistan test opener Ahmed Shehzad knows he had a lucky escape when a short-pitched ball cracked his cheekbone earlier this month and says he "froze" when he heard the news of Australian batsman Phil Hughes' death on Thursday. Hughes died in a Sydney hospital two days after being struck by a ball that led to a "catastrophic" injury which caused "massive" bleeding to his brain. ...
  • Cricket-'Freakish accident' gave Hughes little chance of survival - doctors
    SYDNEY, Nov 27 (Reuters) - The death of Australian cricketer Phillip Hughes was caused by a "freakish accident" that gave the 25-year-old international batsman little chance of survival, his doctors said on Thursday. Hughes was struck by a short-pitched delivery on Tuesday while playing in a domestic match and died in St Vincent's hospital on Thursday having never regained consciousness. "I think in this instance, this was a freakish accident because it was an injury to the neck that caused haemorrhage in the brain. ...
  • Cricket-Reaction to the death of Phillip Hughes
    * Australian PM leads tributes * "a shocking aberration," says Abbott (Updates with more reaction) SYDNEY, Nov 27 (Reuters) - Australian cricketer Phillip Hughes died in hospital on Thursday, two days after the batsman was struck on the head by a bouncer during a domestic match. Australian Prime Minister Tony Abbott led a flood of tributes for the 25-year-old. - - - "His death is a very sad day for cricket and a heartbreaking day for his family. What happened has touched millions of Australians. For a young life to be cut short playing our national game seems a shocking aberration. ...
  • Cricket-Australia's Hughes dies after being hit by ball
    * Hughes suffers "massive" brain bleeding * Hughes dies two days after emergency surgery * Tributes flood social media (Recasts, adds quotes, details) By Swati Pandey SYDNEY, Nov 27 (Reuters) - Australian cricketer Phillip Hughes died in a Sydney hospital on Thursday, two days after being struck by a ball that led to a "catastrophic" injury which caused "massive" bleeding to his brain and ultimately proved fatal. ...
  • Ebola vaccine from Glaxo passes early safety test

    A nurse holds a syringe containing an experimental Ebola vaccine during a media visit at the CHUV in LausanneNEW YORK (Reuters) - An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine. The trial, which began on Sept. 2 and will monitor the volunteers for 48 weeks, is primarily aimed at assessing how safe the vaccine is. But the immune response offered hope that it would also be effective. ...


Sherman 4201 Texoma Pkwy (903) 892 -8123 Ardmore 2624 S. Commerce (580) 223-0946
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability
Gray Television, Inc.